MGB Biopharma specializes in the development of innovative anti-infective medications using Minor Groove Binder (MGB) compounds. The company is dedicated to advancing new antibiotics aimed at addressing the growing challenge of antibiotic resistance in the biotechnology and pharmaceutical sectors.
MGB Biopharma belongs to the Biotechnology, Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of MGB Biopharma?
MGB Biopharma specializes in Minor Groove Binder (MGB) technology, Innovative anti-infective medications, Targeting antibiotic-resistant bacteria, Clinical development of MGB-BP-3, Novel mechanism of action for antibiotics.
What products and services is MGB Biopharma likely to offer?
MGB Biopharma offers Antibiotics, Anti-infective medications, Clinical development services, Drug discovery, Research and development.
Who are the competitors of MGB Biopharma?
Competitors of MGB Biopharma are CureVac, Spero Therapeutics, Melinta Therapeutics, Nabriva Therapeutics, Moderna, Zymeworks.
What does MGB Biopharma do?
MGB Biopharma specializes in the development of innovative anti-infective medications using Minor Groove Binder (MGB) compounds. The company is dedicated to advancing new antibiotics aimed at addressing the growing challenge of antibiotic resistance in the biotechnology and pharmaceutical sectors.